BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 27147960)

  • 1. The Biochemistry and Epigenetics of Epilepsy: Focus on Adenosine and Glycine.
    Boison D
    Front Mol Neurosci; 2016; 9():26. PubMed ID: 27147960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetics and epilepsy prevention: The therapeutic potential of adenosine and metabolic therapies.
    Boison D; Rho JM
    Neuropharmacology; 2020 May; 167():107741. PubMed ID: 31419398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosinergic signaling in epilepsy.
    Boison D
    Neuropharmacology; 2016 May; 104():131-9. PubMed ID: 26341819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of adenosine in epilepsy.
    Weltha L; Reemmer J; Boison D
    Brain Res Bull; 2019 Sep; 151():46-54. PubMed ID: 30468847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of DNA Methylation and Adenosine in Ketogenic Diet for Pharmacoresistant Epilepsy: Focus on Epileptogenesis and Associated Comorbidities.
    Chen F; He X; Luan G; Li T
    Front Neurol; 2019; 10():119. PubMed ID: 30863356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine Dysfunction in Epilepsy and Associated Comorbidities.
    Guo M; Li T
    Curr Drug Targets; 2022; 23(4):344-357. PubMed ID: 34602036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The holy grail of epilepsy prevention: Preclinical approaches to antiepileptogenic treatments.
    Löscher W
    Neuropharmacology; 2020 May; 167():107605. PubMed ID: 30980836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketogenic diet prevents epileptogenesis and disease progression in adult mice and rats.
    Lusardi TA; Akula KK; Coffman SQ; Ruskin DN; Masino SA; Boison D
    Neuropharmacology; 2015 Dec; 99():500-9. PubMed ID: 26256422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis.
    Williams-Karnesky RL; Sandau US; Lusardi TA; Lytle NK; Farrell JM; Pritchard EM; Kaplan DL; Boison D
    J Clin Invest; 2013 Aug; 123(8):3552-63. PubMed ID: 23863710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Epigenetics of Epilepsy and Its Progression.
    Hauser RM; Henshall DC; Lubin FD
    Neuroscientist; 2018 Apr; 24(2):186-200. PubMed ID: 28468530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient use of a systemic adenosine kinase inhibitor attenuates epilepsy development in mice.
    Sandau US; Yahya M; Bigej R; Friedman JL; Saleumvong B; Boison D
    Epilepsia; 2019 Apr; 60(4):615-625. PubMed ID: 30815855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homeostatic control of brain function - new approaches to understand epileptogenesis.
    Boison D; Sandau US; Ruskin DN; Kawamura M; Masino SA
    Front Cell Neurosci; 2013; 7():109. PubMed ID: 23882181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic interventions for epileptogenesis: A new frontier for curing epilepsy.
    Younus I; Reddy DS
    Pharmacol Ther; 2017 Sep; 177():108-122. PubMed ID: 28279785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy.
    Löscher W
    Epilepsy Res; 2002 Jun; 50(1-2):105-23. PubMed ID: 12151122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcosine Suppresses Epileptogenesis in Rats With Effects on Hippocampal DNA Methylation.
    Shen HY; Weltha L; Cook JM; Gesese R; Omi W; Baer SB; Rose RM; Reemmer J; Boison D
    Front Mol Neurosci; 2020; 13():97. PubMed ID: 32581708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetics of Epileptogenesis-Evoked Upregulation of Matrix Metalloproteinase-9 in Hippocampus.
    Zybura-Broda K; Amborska R; Ambrozek-Latecka M; Wilemska J; Bogusz A; Bucko J; Konopka A; Grajkowska W; Roszkowski M; Marchel A; Rysz A; Koperski L; Wilczynski GM; Kaczmarek L; Rylski M
    PLoS One; 2016; 11(8):e0159745. PubMed ID: 27505431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease modification in partial epilepsy.
    Walker MC; White HS; Sander JW
    Brain; 2002 Sep; 125(Pt 9):1937-50. PubMed ID: 12183340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The methylation hypothesis: do epigenetic chromatin modifications play a role in epileptogenesis?
    Kobow K; Blümcke I
    Epilepsia; 2011 Jul; 52 Suppl 4():15-9. PubMed ID: 21732935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine dysfunction and adenosine kinase in epileptogenesis.
    Boison D
    Open Neurosci J; 2010 Jan; 4():93-101. PubMed ID: 20730044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of epilepsy].
    Legido A
    Rev Neurol; 2002 Jan 16-31; 34(2):186-95. PubMed ID: 11988916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.